类风湿病患者对药物的信仰与治疗坚持之间的关联
Özlem Kardaş Kin1, Arzu Güngör Tolasa2
1Gaziantep Islamic Science and Technology University, Gaziantep, Türkiye.
Revista da Escola de Enfermagem da U S P
|January 9, 2026
概括
患者对药物的信仰显著影响了风湿病学治疗的坚持. 较高的药物焦虑与较低的坚持相关,强调需要解决患者的担忧,以获得更好的结果.
科学领域:
- 类风湿病学 类风湿病学
- 心理学 心理学 心理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物信仰和坚持是治疗慢性风湿性疾病的关键.
- 了解影响治疗坚持的因素可以改善患者的治疗结果.
研究的目的:
- 调查类风湿病患者的药物信仰与他们的治疗坚持之间的关系.
- 在土耳其的风湿病学队列中,确定与药物信仰和药物坚持相关的因素.
主要方法:
- 使用了一种描述性研究设计,包括来自土耳其的风湿病诊所的311名患者.
- 数据采集使用了风湿病学合规问卷 (CQR) 和药物信仰问卷 (BMQ-T).
主要成果:
- 所有参与者都表现出不坚持治疗.
- 在药物信念 (BMQ) 和药物坚持 (CQR) 之间发现了显著的关联 (p < 0.05).
- 在男性和失业者中发现了更高的坚持,而药物信仰与婚姻状况和使用时间有关. 增加对药物的焦虑与较低的坚持相关.
结论:
- 患者对药物的信念对风湿病学治疗的坚持有很大影响.
- 解决与药物相关的焦虑是提高患者坚持治疗和有效管理类风湿病的关键.
相关概念视频
Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239
Rheumatic Heart Disease III: Medical Management
278
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
278
The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
301
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
301
Rheumatic Heart Disease IV: Nursing Management
262
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
262
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143


